NEW YORK (Reuters Health) – Sertraline plus naltrexone is more effective than either agent alone in promoting abstinence in depressed alcohol-dependent patients, according to study findings in the…
NEW YORK (Reuters Health) – Augmenting antipsychotic treatment with citalopram can reduce suicidal ideation in schizophrenic patients with subthreshold depressive symptoms, a new study shows. And among patients…
NEW YORK (Reuters Health) – The anticonvulsant topiramate (Topamax) helps treat alcohol dependence, but serious side effects might limit its use, researchers say. In their systematic review, Dr.…
NEW YORK (Reuters Health) – In treating social anxiety disorder, phenelzine combined with cognitive behavioral group therapy achieves a higher response rates than either treatment alone or placebo,…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses new treatment options for depression, particularly deep brain stimulation and injectable treatment…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…
NEW YORK (Reuters Health) – Stimulant medications show greater efficacy than nonstimulants for treating attention-deficit/hyperactivity disorder (ADHD) in adults, according to a new meta-analysis. Study authors Dr. Stephen…
Gary Small, MD, Director, UCLA Center on Aging, University of California, Los Angeles, discusses a recent study, “Your Brain on Google” in which blood flow patterns were compared…